Skip to content
Screener

McKesson MCK Restructuring Charges

Discontinued — last reported Q2 '18

Restructuring Charges at other companies

Cardinal Health logo
Cardinal HealthCAH
$25M-10.7%
Cencora logo
CencoraCOR
$60.63M+45.1%
Merck & Co. logo
Merck & Co.MRK
$151M-73.0%

Segments

By segment

See full
Prescription Technology Solutions$61M—
Medical-Surgical Solutions$23M+35.3%
North American Pharmaceutical$2M—

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$101.59B+15.6%
Enterprise value$109.31B+13.4%
P/E22.1×-5.7×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%—
Debt / equity2×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The source filing: McKesson’s 10-Q, filed October 27, 2017. Open the filing →

Filed
Oct 26, 2017, 8:00 PM EDT
Fiscal quarter
Q2 FY2018
Calendar quarter
Q3 2017
Accession
0000927653-17-000018

FAQ

What does restructuring charges mean?
One-time costs from reorganizing operations, including employee severance, facility closure costs, contract termination fees, and asset relocation expenses.